These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9485016)

  • 1. Alpha-hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts.
    Shibutani S; Dasaradhi L; Terashima I; Banoglu E; Duffel MW
    Cancer Res; 1998 Feb; 58(4):647-53. PubMed ID: 9485016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts.
    Shibutani S; Shaw PM; Suzuki N; Dasaradhi L; Duffel MW; Terashima I
    Carcinogenesis; 1998 Nov; 19(11):2007-11. PubMed ID: 9855017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the stereoisomers of alpha-hydroxytamoxifen with human hydroxysteroid sulfotransferase SULT2A1 and rat hydroxysteroid sulfotransferase STa.
    Apak TI; Duffel MW
    Drug Metab Dispos; 2004 Dec; 32(12):1501-8. PubMed ID: 15371299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers.
    Kim SY; Laxmi YR; Suzuki N; Ogura K; Watabe T; Duffel MW; Shibutani S
    Drug Metab Dispos; 2005 Nov; 33(11):1673-8. PubMed ID: 16099924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.
    Kim SY; Suzuki N; Laxmi YR; McGarrigle BP; Olson JR; Sharma M; Sharma M; Shibutani S
    Chem Res Toxicol; 2005 May; 18(5):889-95. PubMed ID: 15892583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hepatic tamoxifen-DNA adducts in mice: alpha-(N(2)-deoxyguanosinyl)tamoxifen and alpha-(N(2)-deoxyguanosinyl)tamoxifen N-oxide.
    Umemoto A; Monden Y; Suwa M; Kanno Y; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S; Komaki K
    Carcinogenesis; 2000 Sep; 21(9):1737-44. PubMed ID: 10964106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Hydroxytamoxifen sulfation metabolism.
    Chen G; Yin S; Maiti S; Shao X
    J Biochem Mol Toxicol; 2002; 16(6):279-85. PubMed ID: 12481303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts.
    Boocock DJ; Maggs JL; Brown K; White IN; Park BK
    Carcinogenesis; 2000 Oct; 21(10):1851-8. PubMed ID: 11023543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of lower genotoxicity of toremifene compared with tamoxifen.
    Shibutani S; Ravindernath A; Terashima I; Suzuki N; Laxmi YR; Kanno Y; Suzuki M; Apak TI; Sheng JJ; Duffel MW
    Cancer Res; 2001 May; 61(10):3925-31. PubMed ID: 11358807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.
    Umemoto A; Monden Y; Lin CX; Abdul-Momen M; Ueyama Y; Komaki K; Laxmi YR; Shibutani S
    Chem Res Toxicol; 2004 Dec; 17(12):1577-83. PubMed ID: 15606132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-hydroxylation of tamoxifen and toremifene by human and rat cytochrome P450 3A subfamily enzymes.
    Kim SY; Suzuki N; Santosh Laxmi YR; Rieger R; Shibutani S
    Chem Res Toxicol; 2003 Sep; 16(9):1138-44. PubMed ID: 12971802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen.
    Pathak DN; Pongracz K; Bodell WJ
    Carcinogenesis; 1996 Sep; 17(9):1785-90. PubMed ID: 8824496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice.
    Umemoto A; Komaki K; Monden Y; Suwa M; Kanno Y; Kitagawa M; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S
    Chem Res Toxicol; 2001 Aug; 14(8):1006-13. PubMed ID: 11511174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen.
    Dasaradhi L; Shibutani S
    Chem Res Toxicol; 1997 Feb; 10(2):189-96. PubMed ID: 9049430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
    Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
    Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic potential of alpha-(N2-deoxyguanosinyl)tamoxifen lesions, the major DNA adducts detected in endometrial tissues of patients treated with tamoxifen.
    Terashima I; Suzuki N; Shibutani S
    Cancer Res; 1999 May; 59(9):2091-5. PubMed ID: 10232593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction.
    Davis W; Hewer A; Rajkowski KM; Meinl W; Glatt H; Phillips DH
    Cancer Res; 2000 Jun; 60(11):2887-91. PubMed ID: 10850433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene.
    Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM
    Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
    Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
    Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.